0001209191-22-015921.txt : 20220303 0001209191-22-015921.hdr.sgml : 20220303 20220303194045 ACCESSION NUMBER: 0001209191-22-015921 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORASH LAURENCE M CENTRAL INDEX KEY: 0001193209 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 22711414 MAIL ADDRESS: STREET 1: C/O CERUS CORP STREET 2: 2411 STENWELL DRIVE CITY: CONCORD STATE: CA ZIP: 94520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-01 0 0001020214 CERUS CORP CERS 0001193209 CORASH LAURENCE M C/O CERUS CORPORATION 1220 CONCORD AVE SUITE 600 CONCORD CA 94520 0 1 0 0 Chief Scientific Officer Restricted Stock Unit 2022-03-01 4 A 0 45000 0.00 A 2072586 D Option (Right to Buy) 5.76 2022-03-01 4 A 0 90000 A 2032-02-28 Common Stock 90000 90000 D Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Not applicable. Laurence M. Corash by Chrystal Menard, attorney-in-fact 2022-03-03